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The Common NF-κB Essential Modulator (NEMO) Gene 
Rearrangement in Korean Patients with Incontinentia Pigmenti 
Incontinentia pigmenti (IP) is a rare X-linked dominant disorder characterized by highly 
variable abnormalities of the skin, eyes and central nervous system. A mutation of the 
nuclear factor-κB essential modulator (NEMO) located at Xq28 is believed to play a role in 
pathogenesis and the mutation occurs mostly in female patients due to fatal consequence 
of the mutation in males in utero. This study was designed to identify the common NEMO 
rearrangement in four Korean patients with IP. Deletion of exons 4 to 10 in the NEMO, the 
most common mutation in IP patients, was detected in all of the patients by the use of 
long-range PCR analysis. This method enabled us to discriminate between NEMO and 
pseudogene rearrangements. Furthermore, all of the patients showed skewed XCI patterns, 
indicating pathogenicity of IP was due to cells carrying the mutant X chromosome. This is 
the first report of genetically confirmed cases of IP in Korea.
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INTRODUCTION
Incontinentia pigmenti (IP; MIM 308300) is a rare X-linked dom-
inant disorder characterized by abnormal skin pigmentation, 
retinal detachment and central nervous system defects (1, 2). 
This syndrome is typically lethal in male but female patients 
survive as cells expressing the mutant X-chromosome are se-
lectively inactivated. Such negative selection usually results in 
IP female patients showing an extremely skewed X-chromo-
some inactivation (XCI) pattern as compared to approximately 
10% in a healthy population (3, 4).
  The pathogenesis of IP is associated with mutations in the 
nuclear factor κB essential modulator (NEMO), also known as 
IKBKG (IKK-gamma gene). The NEMO encodes a regulatory 
component of the IkB kinase complex that is required for the 
activation of the transcription factor NF-κB and is fundamental 
for cell development, survival and function (5). The gene, locat-
ed on chromosome Xq28, is composed of 10 exons with three 
alternative noncoding exons. A highly homologous pseudogene, 
so-called ‘∆NEMO’ , also exists within a 35.5 kb duplicated frag-
ment opposite to NEMO, and contain NEMO exons 3 to 10. A 
large deletion of NEMO exons 4 to 10 is found in approximately 
80% of IP patients, whereas other mutations such as small nu-
cleotide substitution, deletion and insertion account for a small 
proportion of patients (5, 6). The deletion alters sequence after 
nucleotide 399 (from ATG) in the NEMO mRNA and leads to a 
truncated protein containing the first 133 N-terminal amino ac-
ids (1). Although many IP patients have been described in the 
literature (7), there are no genetically confirmed patients in Ko-
rea. In this study, we performed a genetic analysis for Korean 
patients clinically diagnosed with IP and found the common 
genomic rearrangement that involved the deletion of exons 4 to 
10 in NEMO.
 
CASE REPORT
Clinical findings
Four unrelated female patients with clinical features of IP were 
evaluated. All patients were diagnosed shortly after birth as pre-
senting with progressive erythema, vesicular rash and linear 
hyperpigmentation on the limbs and trunk. Patient 1 was a 15- 
month-old girl who presented with a linear vesicular eruption 
on the extremities since birth. On examination, the patient had 
vesicles and crusted lesions on the extremities, accompanied 
by swirled hyperpigmentation on the arm, foot and abdomen 
(Fig. 1A). A fundus examination reveal  ed retinal hemorrhage 
and macular hypopigmentation in both eyes (Fig. 1B, C). There 
was no family history of skin disease. Patient 2 was a 19-month-Song M-J, et al.  •  NEMO Rearrangement in Incontinentia Pigmenti
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old girl, with a recurrent linear vesicular eruption on the extrem-
ities since birth. The patient had no family history of skin disease. 
Hematological analysis on admission showed marked eosino-
philia (32%) with leukocytosis (23,000/µL). A fundus examina-
Fig. 1. Clinical features of Patient 1. (A) 
Lower leg of Patient 1, showing the hyper­
pigmented lesion along with Blaschko’s 
lines on the posterior part of the lower 
limbs. Fundus photographs of the left eye 
(B) and right eye (C), showing retinal hemor­
rhage and macular hypopigmentation. A
B
C
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Fig. 2. Schematic representation of NEMO and ∆NEMO pseudogene location in Xq28. (A) NEMO gene (      ), ∆NEMO pseudogene (      ), (B) rearranged NEMO gene (      ), 
∆NEMO pseudogene (       ). In multiplex PCR, forward primers are Int3s (5´­CCA CTC AGG GCT TAG AGC GC­3´) and Rep3s (5´­CTC TTT TGA CAA GAA CAC CGG A­3´). Int3s, 
located within intron 3, matches with the wild­type and rearranged NEMO and pseudogene as well. Rep3s matches with two direct repeats (     ) on both the wild­type NEMO 
and pseudogene, while it matches with the unique remaining direct repeat on the rearranged NEMO and pseudogene. L2Rev (5´­TCG GAG ACA CAG GAA CCA GCA­3´) is the 
reverse primer. In long­range PCR, In2 (5´­GAG GAC CAA TAC CGA GCA TC­3´) and JF3R (5´­CTC GGA GAC ACA GGA ACC AGC A­3´) primers amplify a 2.6­kb gene­specific 
band. JF3R and Rev­2 (5´­GCC ATC TGT TTT TGC GTG TG­3´) primers reveal a 2.5­kb pseudogene­specific band.Song M-J, et al.  •  NEMO Rearrangement in Incontinentia Pigmenti
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tion revealed retinal hemorrhage in the left eye and develop-
mental milestones were delayed. The mother of the patient had 
multiple miscarriages. Patient 3 was a 21-month-old girl who 
also presented with characteristic features of IP including hy-
perpigmented skin lesions, hypodontia and a family history of 
skin disease. Slightly delayed developmental milestones were 
also observed. The mother was noted to have similar skin man-
ifestations and the maternal grandmother had two episodes of 
miscarriage. Patient 4 was a 27-yr-old female who had one pre-
vious miscarriage at 13 weeks gestation. She was diagnosed with 
IP based on skin manifestations and a family history of skin dis-
ease during early childhood (her mother and older sister had 
similar skin manifestation). A physical examination was unre-
markable other than skin manifestation. 
A recurrent mutation in NEMO
After obtaining written informed consent, PCR-based analyses 
were performed in the four patients, the parents of Patient 3 and 
two healthy control subjects in February, 2008. This study was 
approved by the Samsung Medical Center Institutional Review 
Board. Multiplex PCR was performed to identify the common 
deletion as either NEMO or ∆NEMO by using two forward prim-
ers (Int3s and Rep3s) and one single reverse primer (L2Rev), 
described by Steffann et al. (Fig. 2) (8). A 1045-bp sized product 
was expected for the deletion involving exons 4 to 10 of either 
the NEMO or ∆NEMO (Int3s and L2Rev), whereas a 733-bp prod-
uct was expected in all tested participants as an internal ampli-
fication control (Rep3s and L2Rev). Confirmatory long-range 
PCR was also performed to detect the specific genetic rearrange-
ment of the NEMO, described by Bardaro et al. (9). A 2.6-kb prod-
uct was expected for the pathological NEMO deletion with a for-
ward primer (In2) and a reverse primer (JF3R). In a comparative 
PCR assay performed with JF3R and a ∆NEMO-specific reverse 
primer (Rev-2), a 2.5-kb product was expected for the ∆NEMO 
deletion. 
  For the multiplex PCR analysis, all tested individuals showed 
the 733-bp product, whereas only the four female patients and 
the mother of Patient 3 showed the 1045-bp product (Fig. 3A). 
For the long-range PCR analysis, the expected 2.6-kb product 
was seen in only the four patients and the mother of Patient 3 
(Fig. 3B). Also, in a comparative PCR assay performed with JF3R 
and a ∆NEMO–specific reverse primer (Rev-2), the expected 2.5-
kb product was not detected in all tested individuals. These re-
sults indicate that the deletion was in the NEMO and not in the 
∆NEMO.
X-inactivation analysis
The XCI pattern was determined by PCR analysis of a polymor-
phic CAG repeat in the HUMARA (10). After digestion with the 
methylation sensitive enzyme HpaII, a PCR product is obtained 
only from the inactive X-chromosome. The PCR products were 
analyzed by GeneScan Software. XCI was calculated as the ratio 
between the intensities of the PCR products of the two alleles 
with the smallest allele given first. The presence of skewed XCI 
was considered if the ratio was ≥65:35, and considered extreme-
ly skewed if the ratio was ≥80:20 (11). The heterozygous alleles 
of the X-chromosomes in each non-digested sample were shown 
with a CAG repeat polymorphism (Fig. 4). After DNA was digest-
ed with HpaII, Patient 1, Patient 4 and the mother of Patient 3 
Fig. 4. XCI analyses in affected female in­
dividuals. After digestion with HpaII, a PCR 
product is obtained from the inactive X chro­
mosome only. The red star (    ) in Patient 3 
indicates the maternal allele (273­bp).
HpaII -
X inactivation
Patient 1
0 : 100 28 : 72 66 : 34 100 : 0 100 : 0
Patient 2 Patient 3 Patient 4 Mother of Pt 3
HpaII + 
1 3 2 4 3-F 3-M C1 C2
Fig. 3. Representative results of multiplex­PCR and long­PCR analysis. (A) Multiplex 
PCR products in all participants and controls (C1, C2). A 1045­bp band corresponding 
to DNA amplification between the Int3s and L2Rev primers indicates the presence of 
the common rearrangement found only in IP affected individuals. A 733­bp product 
serves as an internal control of DNA amplification (Rep3s and L2Rev primers). (B) 
Result of long­range PCR analysis. The specific NEMO deletion corresponds to the 
2.6­kb band (In2 and JF3R primers) detected in the patients as well as in the mother 
of Patient 3 (3­M). 3­F, the father of Patient 3.
1,045 bp
733 bp
2.6 bp
A
BSong M-J, et al.  •  NEMO Rearrangement in Incontinentia Pigmenti
1516   http://jkms.org DOI: 10.3346/jkms.2010.25.10.1513
showed only one of the heterozygous alleles, indicating that these 
had a highly skewed XCI. Patient 2 and Patient 3 showed one 
distinct peak and one faint peak. These results indicate that all 
affected individuals had a skewed XCI, although the degree of 
skewing was different.
DISCUSSION
Bardaro et al. have reported the use of a long-range PCR meth-
od that discriminates between rearrangement in the NEMO 
and ∆NEMO, thus enabling molecular diagnosis for IP (9). How-
ever, the absence of an internal control for PCR precludes dis-
crimination between PCR failure in rearranged individuals and 
the absence of NEMO or ∆NEMO rearrangement, giving false-
negative results. Subsequently, Steffann et al. proposed the use 
of a multiplex PCR method to overcome these limitations (8).
  In this study, all affected individuals showed an identical ge-
nomic rearrangement involving a deletion of exons 4 to 10 of 
the NEMO. It has been reported that in Western countries, an 
identical genomic deletion accounts for 80% of the identified 
mutations in the NEMO (5). As the same mutation was found 
in Korean and Japanese IP patients (12, 13), the deletion may 
be the most common mutational hot spot irrespective of the 
ethnic background, although the number of the patients was 
limited.
  In this study, the method proposed by Bardaro et al. has been 
demonstrated to be reproducible; however, we experienced dif-
ficulty to identify optimal PCR conditions for DNA amplifica-
tion. In addition, long-range PCR is a time-intensive and labor-
intensive method as compared with multiplex PCR. Therefore, 
we suggest that the multiplex PCR proposed by Steffann et al. 
may be useful for screening the existence of the NEMO rear-
rangement for clinically suspicious IP patients, and the use of 
long-range PCR proposed by Bardaro et al. should be consid-
ered as a confirmatory diagnostic tool for patients with positive 
findings with screening multiplex PCR testing.
  All the four patients showed the classical cutaneous signs of 
IP and the observed clinical manifestation spectrum was simi-
lar to that previous Korean IP study report by Kim et al. (14). For 
the XCI analysis, all affected individuals showed a skewed XCI 
pattern. Two patients (Patients 1 and 4) and the mother of Pa-
tient 3 showed an extremely skewed XCI and two patients (Pa-
tients 2 and 3) showed mild skewing of XCI. The XCI phenotype 
might be related to the disease phenotype, since Patients 2 and 
3 showed relatively severe clinical manifestations such as de-
velopmental delay, hypodontia and retinopathy, although all 
affected individuals had the same mutation. Martinez-Pomar 
et al. (15) described an IP patient with severe clinical manifes-
tations in the first 30 months of life. At that time, the patient 
showed a random XCI pattern. At the age of 42 months, howev-
er, all clinical signs disappeared, and a completely skewed XCI 
pattern was observed. Therefore, XCI could modify the clinical 
phenotype of IP, but has limitations to explain all of the pheno-
typic manifestations of IP. 
  This is the first report of genetically confirmed IP patients in 
Korea. The patients showed a common genomic rearrangement 
involving the deletion of exons 4 to 10 in NEMO and the muta-
tion spectrum was similar to that previously reported. Although 
only a small number of patients was investigated, this study in-
dicates that the genetic analysis of the NEMO may be helpful 
for rapid confirmation of IP diagnosis, prenatal diagnosis and 
carrier detection. 
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